GST-π is one of the main members of the GSTs family, and the main mechanism is to degrade drugs by catalysing glutathione and various electrophilic compounds, which weakens the therapeutic effect of chemotherapy drugs on tumours and thus enhances the drug resistance of cancer cells. Here, GSTP1 is linked to neoplasm.